Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment

14:45 EDT Outlook jumps 24% to $1.64 after FDA approves wet AMD treatmentClaim 55% Off TipRanks Unlock powerful investing tools with TipRanks Pr...

Raccontata damarkets.businessinsider.com